Posts by Muana Minkoué
Bilan’s 2024 Top 40 entrepreneurs below 40 in Western Switzerland
Bilan Magazine identifies the founders of companies under 40, with sales of CHF 1 million or more. This annual operation highlights the achievements and projects of the new generation at the helm of fast-growing companies. Check out the Swiss Health Valley entrepreneurs listed in the third edition of the Top 40 Entrepreneurs Under…
Read MoreSIB Profile 2024 – Data scientists for life
The Swiss Institute of Bioinformatics (SIB) latest activity report sets out how SIB contributes to Switzerland’s influence in the life sciences, from fighting diseases or supporting innovation to promoting scientific excellence and open science. This year’s report focuses on two themes: the revolution that generative artificial intelligence is bringing to life science research, and…
Read MoreDamian Müller elected Swiss Medtech President
Damian Müller was elected President of Swiss Medtech at its last General Meeting. The 39-year-old Council of States member from Lucerne succeeds Beat Vonlanthen, who is handing over leadership of the Swiss medical technology association after six years. The Assembly also elected two female entrepreneurs, Juliette von Arx, CEO of Lifestage Solutions AG,…
Read MoreHeroSupport wins Prix Strategis
The 31st Prix Strategis closing ceremony crowned start-up Herosupport. Last night, HeroSupport SA distinguished themselves among 90 innovative competitors to win this year’s Prix Strategis , along with CHF 50,000. Their groundbreaking product, VENUS SHELL™, a personalized 3D-printed solution, is transforming radiation treatment by enhancing MRI accuracy and improving patient comfort. Every year…
Read MoreDiabète, Même Pas Peur ! wins the FIT Impact grand prize
The Foundation for Technological Innovation (FIT) has awarded its very first FIT Impact award. The Foundation has launched the FIT Impact programme to supports projects that do not require a technological or digital dimension. Diabète, Même Pas Peur ! wins CHF 20’000. Diabète, Même Pas Peur ! aims to to turn the challenges of…
Read MoreDAAV secures CHF 1 Million
DAAV, a pioneering startup revolutionising mobility services for people with reduced mobility, announced the successful closure of its first funding round. The investment was led by Spicehaus Partners. DAAV is dedicated to providing an inclusive travel experience for individuals with reduced mobility, particularly in airport settings. With its AI-enabled mobility device, DAAV-air, the…
Read MoreI-Teams – Call for Projects
Apply before 15 September 2026 for the I-Teams programme The main goal of the i-Teams Programme is to translate high-potential medical technologies through the collaboration between a research group and an i-Team. Using the expert knowledge of the inventors, each team will use creative and innovative approaches to find the best way to commercialize the…
Read MoreTestmate Health raises $6 Million
Testmate Health announced the successful closing of their $6 Million funding round led by RH Capital to continue their development of the first at-home rapid test for sexually transmitted infections (STIs). The round was led by women’s health fund RH Capital, with participation from Tia and Oova backer The Helm, Dame and Playground…
Read MoreAspivix announced first gynaecological procedures performed in the US
The Biopôle-based startup announced a groundbreaking achievement in the United States with the first patients benefiting from successful IUD placement and transcervical procedures using its innovative cervical device. The first patients in the United States with successful procedures The first gentle procedures were successfully performed by Alissa M. Conklin, MD. an Assistant Professor…
Read MoreHealthCare Konnect and Lucida Medical announce strategic partnership for prostate cancer diagnosis
Healthcare Konnect (HCK) and Lucida Medical partner to extend the distribution of Innovative AI-driven technology, PiTM, for prostate cancer detection, in Switzerland and Morocco. Prostate cancer is the second most common cancer in men worldwide, and the number of new cases is expected to double between 2020 and 2040. Early and accurate detection…
Read More